APA

Reich K., Segaert S., Van de Kerkhof P., Durian C., Boussuge M. P., Paolozzi L., Wajdula J. & Boggs R. (20100119). Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis. : Dermatology (Basel, Switzerland).

Chicago

Reich Kristian, Segaert Siegfried, Van de Kerkhof Peter, Durian Cis, Boussuge Marie Pierre, Paolozzi Laurence, Wajdula Joseph and Boggs Robert. 20100119. Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis. : Dermatology (Basel, Switzerland).

Harvard

Reich K., Segaert S., Van de Kerkhof P., Durian C., Boussuge M. P., Paolozzi L., Wajdula J. and Boggs R. (20100119). Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis. : Dermatology (Basel, Switzerland).

MLA

Reich Kristian, Segaert Siegfried, Van de Kerkhof Peter, Durian Cis, Boussuge Marie Pierre, Paolozzi Laurence, Wajdula Joseph and Boggs Robert. Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis. : Dermatology (Basel, Switzerland). 20100119.